Alembic Pharma to raise up to 300 cr via NCD
The board of Alembic Pharmaceuticals has approved a proposal to raise up to 300 crore through non-convertible debentures on private placement basis.10-09-2018
10-09-2018
Outcome of Board Meeting
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter-alia (i) approved the Issue of Unsecured Listed Non-Convertible Debentures (NCDs) of upto Rs. 300 Crores on Private Placement Basis and (ii) Constituted NCD Committee for issue and allotment of NCDs....10-09-2018
Board Meeting Intimation for Issue Of Non-Convertible Debentures On Private Placement Basis
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2018 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Monday, 10th September, 2018, inter-alia to consider and approve the proposal for issue of Non-Convertible Debentures on Private Placement Basis. Kindly take the same on record.05-09-2018
Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that CRISIL Limited ('CRISIL') has vide its letter dated 5th September, 2018 assigned us the following credit ratings: 1. Reaffirmed the credit rating of ''CRISIL AA+/Stable' for Rs. 850 Crores limit of fund & non-fund based facilities and term loans....05-09-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the legal heir(s) of the registered shareholder(s) in English language newspaper - Business Standard on 30th August, 2018. We request you to kindly take the same on record.30-08-2018
Updated Contact Details Of Key Managerial Personnel / Senior Officials Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the captioned matter, please find below the updated contact details of persons authorised for the purpose of determining materiality of an event or information and for making disclosures to the Stock Exchange, pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015: Name of Key Managerial Personnel/Senior Officials Designation Contact Details...28-08-2018
Alembic Pharma gets tentative USFDA nod for ophthalmic solution
Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for Bimatoprost Ophthalmic Solution, used t06-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03%. Please find enclosed herewith our press release. We request you to kindly take the same on record.06-08-2018
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
With reference to the captioned matter, this is to inform the exchange that the members of the Company at their 8th Annual General Meeting held on 27th July, 2018 have approved the amendment to the Memorandum of Association and adopted the new set of Articles of Association of the Company. In view of above, the updated Memorandum and Articles of Association of the Company is placed on the website of the Company at the following web-link:...01-08-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alembic Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-07-2018